5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815 · cited 1×
“For combinations with irinotecan or oxaliplatin response rates up to 60% have been reported(2-6) for colon cancer.”
BackgroundDouillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256 · cited 1×
“For combinations with irinotecan or oxaliplatin response rates up to 60% have been reported(2-6) for colon cancer.”
BackgroundSimplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,494
Giacchetti, S., Perpoint, B., Zidani, R., Le Bail, N., Faggiuolo, R., Focan, C., Chollet, P., Llory, J. F., Letourneau, Y., Coudert, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.136 · Cited by 1,403
Salonga, D. S., Danenberg, K. D., Johnson, M. R., Metzger, R., Groshen, S. G., Tsao-Wei, D. D., Lenz, H.-J., Leichman, C. G., Leichman, L., Diasio, R. B., et al. (2000) · PubMed · Cited by 829
Leichman, C. G., Lenz, H. J., Leichman, L., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M., & Danenberg, P. V. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3223 · Cited by 475
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
Peters, G. J., Backus, H. H. J., Freemantle, S., van Triest, B., Codacci-Pisanelli, G., van der Wilt, C. L., Smid, K., Lunec, J., Calvert, A. H., Marsh, S., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00082-0 · Cited by 420
Self-citationLenz, H. J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.176 · Cited by 347
Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.
Sobrero, A. F., Aschele, C., & Bertino, J. R. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.368 · Cited by 336
André, T., Louvet, C., Maindrault-Goebel, F., Couteau, C., Mabro, M., Lotz, J. P., Gilles-Amar, V, Krulik, M., Carola, E., Izrael, V, et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00150-1 · Cited by 267
Pritchard, D. M., Watson, A. J. M., Potten, C. S., Jackman, A. L., & Hickman, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1795 · Cited by 198
Peters, G. J., van der Wilt, C. L., van Groeningen, C. J., Smid, K., Meijer, S., & Pinedo, H. M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2035 · Cited by 196
Self-citationPeters, G. J., Laurensse, E. J., LEYVA, A., Lankelma, J., & Pinedo, H. M. (1986) · PubMed · Cited by 193
Self-citationAn alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug
Ghoshal, K., & Jacob, S. T. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00040-3 · Cited by 164
Folate-based thymidylate synthase inhibitors as anticancer drugs
Jackman, A. L., & Calvert, A. H. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059353 · Cited by 160
Antifolate Drugs in Cancer Therapy
(1999) · Humana Press eBooks · doi:10.1007/978-1-59259-725-3 · Cited by 125
Peters, G. J., Lankelma, J., Kok, R. M., Noordhuis, P., van Groeningen, C. J., van der Wilt, C. L., Meyer, S., & Pinedo, H. M. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685670 · Cited by 118
Self-citationGuichard, S. M., Hennebelle, I., Bugat, R., & Canal, P. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00541-8 · Cited by 107
Schuetz, J. D., Wallace, H., & Diasio, R. B. (1984) · PubMed · Cited by 105
Ghoshal, K., & Jacob, S. T. (1994) · PubMed · Cited by 101
Caradonna, S. J., & Cheng, Y. (1980) · PubMed · Cited by 93
Aschele, C., Debernardis, D., Bandelloni, R., Cascinu, S., Catalano, V., Giordani, P., Barni, S., Turci, D., Drudi, G., Lonardi, S., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf327 · Cited by 49
Fluoropyrimidines as Antifolate Drugs
Peters, G. J., & Köhne, C.-H. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-725-3_5 · Cited by 48
Self-citationInhibition of pre-mRNA splicing by 5-fluoro-, 5-chloro-, and 5-bromouridine
Sierakowska, H., Shukla, R. R., Domiński, Z., & Kole, R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47285-2 · Cited by 48
Backus, H. H. J., van Riel, J. M. G. H., van Groeningen, C. J., Vos, W., Dukers, D. F., Bloemena, E., Wouters, D., Pinedo, H. M., & Peters, G. J. (2001) · Annals of Oncology · doi:10.1023/a:1011112227044 · Cited by 47
Self-citationWebley, S. D., Hardcastle, A., Ladner, R. D., Jackman, A. L., & Aherne, G. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1358 · Cited by 46
Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.
Sawyer, R. C., Stolfi, R. L., Martin, D. S., & Spiegelman, S. (1984) · PubMed · Cited by 46
Mechanisms of excision of 5-fluorouracil by uracil DNA glycosylase in normal human cells.
Mauro, D. J., de Riel, J. K., Tallarida, R. J., & Sirover, M. A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13666-3 · Cited by 40
The Role of Uracil Misincorporation in Thymineless Death
Aherne, G. W., & Brown, S. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-725-3_20 · Cited by 35
van Laar, J. A. M., van der Wilt, C. L., Rustum, Y. M., Noordhuis, P., Smid, K., Pinedo, H. M., & Peters, G. J. (1996) · PubMed · Cited by 33
Self-citationKatsumata, K., Tomioka, H., Sumi, T., Yamashita, S., Takagi, M., Kato, F., Nakamura, R., Koyanagi, Y., Aoki, T., & Kato, K. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0526-3 · Cited by 23
van Riel, J., van Groeningen, C. J., Albers, S. H. M., Cazemier, M., Meijer, S., Bleichrodt, R. P., van den Berg, F. G., Pinedo, H. M., & Giaccone, G. (2000) · Annals of Oncology · doi:10.1023/a:1008369520179 · Cited by 20
Self-citationComella, P., Casaretti, R., Vita, F. D., Avallone, A., Orditura, M., Petrillo, A., Gravina, A., Faranda, A., Comis, S., Comella, G., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008339010655 · Cited by 16
Cited by
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Vodenkova, S., Buchler, T., Cervena, K., Veskrnova, V., Vodicka, P., & Vymetalkova, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107447 · Cited by 956
5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
Zhang, N., Yin, Y., Xu, S.-J., & Chen, W.-S. (2008) · Molecules · doi:10.3390/molecules13081551 · Cited by 771
Noncoding RNAs in gastric cancer: implications for drug resistance
Wei, L., Sun, J., Zhang, N., Zheng, Y., Wang, X., Lv, L., Liu, J., Xu, Y., Shen, Y., & Yang, M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01185-7 · Cited by 468
Liu, Y., Zheng, C., Huang, Y., He, M., Xu, W. W., & Li, B. (2021) · MedComm · doi:10.1002/mco2.55 · Cited by 387
Wei, L., Wang, X., Lv, L., Liu, J., Xing, H., Song, Y., Xie, M., Lei, T., Zhang, N., & Yang, M. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1086-z · Cited by 339
Metadata
- Authors
- Noordhuis, P., Holwerda, U., Van der Wilt, C. L., Van Groeningen, C. J., Smid, K., Meijer, S., Pinedo, H. M., & Peters, G. J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 15
- Issue
- 7
- Pages
- 1025-1032
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2105293285
- Cited by
- 264
- References
- 33
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.